Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 4/2017

14.07.2016 | Interesting Image

Images from 18F-DOPA Scan in Congenital Hyperinsulinism: Not Always a Clue for Diagnosis

verfasst von: Evelina Maines, Luca Giacomello, Mirko D’Onofrio, Matteo Salgarello, Rossella Gaudino, Laura Baggio, Andrea Bordugo

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycaemia in childhood (Horm Res 70:65-72, 2008; J Clin Endocr Metab 93:869-875, 2008). 18−Fluoro-L-dihydroxy-phenylalanine (18F-DOPA) positron emission tomography (PET) can detect areas of increased activity in the pancreas and may differentiate focal from diffuse CHI (J Clin Endocr Metab 93:869-875, 2008; Radiology 253:216-222, 2009). We here report the case of a girl who complained of recurrent episodes of severe hypoglycaemia despite previous partial pancreatectomy. To evaluate the need for additional surgical intervention, we performed 18F-DOPA PET/computed tomography (CT), which showed a focal lesion corresponding to the anatomical region of the pancreatic tail. On the other hand, abdominal magnetic resonance imaging (MRI) clearly demonstrated that the 18F-DOPA uptake was in a loop of bowel occupying the previous surgical bed. Our case highlights that bowel uptake can be a possible pitfall in the interpretation of 18F-DOPA PET/CT in children affected by CHI, suggesting that when 18F-DOPA PET/CT results do not fit the clinical picture, magnetic resonance imaging (MRI) may allow a more accurate correlation of the radiotracer activity with the underlying anatomical or pathological structure.
Literatur
1.
Zurück zum Zitat Mohnike K, Blankenstein O, Minn H, et al. [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res. 2008;70:65–72.CrossRefPubMed Mohnike K, Blankenstein O, Minn H, et al. [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res. 2008;70:65–72.CrossRefPubMed
2.
Zurück zum Zitat Barthlen W, Blankenstein O, Mau H, et al. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2008;93:869–75.CrossRefPubMed Barthlen W, Blankenstein O, Mau H, et al. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2008;93:869–75.CrossRefPubMed
3.
Zurück zum Zitat Capito C, Khen-Dunlop N, Ribeiro MJ, et al. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology. 2009;253:216–22.CrossRefPubMed Capito C, Khen-Dunlop N, Ribeiro MJ, et al. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology. 2009;253:216–22.CrossRefPubMed
4.
Zurück zum Zitat Chondrogiannis S, Marzola MC, Al-Nahhas A, et al. Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. Nucl Med Commun. 2013;34:1141–9.PubMedPubMedCentral Chondrogiannis S, Marzola MC, Al-Nahhas A, et al. Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. Nucl Med Commun. 2013;34:1141–9.PubMedPubMedCentral
Metadaten
Titel
Images from 18F-DOPA Scan in Congenital Hyperinsulinism: Not Always a Clue for Diagnosis
verfasst von
Evelina Maines
Luca Giacomello
Mirko D’Onofrio
Matteo Salgarello
Rossella Gaudino
Laura Baggio
Andrea Bordugo
Publikationsdatum
14.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 4/2017
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-016-0434-9

Weitere Artikel der Ausgabe 4/2017

Nuclear Medicine and Molecular Imaging 4/2017 Zur Ausgabe